1
medial PFC (mPFC) as this region in rodents, and a homologous region in humans, is known to 25 regulate opioid-seeking and inhibitory response control 6, 7 , and encode cognitive flexibility in 26 rodents and humans [8] [9] [10] . Impairments in cognitive control and compulsive drug use in cocaine 27 and heroin addicts is thought to reflect reductions in PFC pyramidal neuron (PN) activity 8,9,11 , 28 however the impact that opioids have on PFC activation, the mechanisms underlying these 29 changes, and resultant effects on cognitive function remains poorly defined. We hypothesized 30 that opioids produce time-dependent shifts in PN excitabilityculminating in basal state 31 hypoactivation that impairs cognitive control, and that the more rapid transition to uncontrollable 32 drug taking in women reflects emergence of hypoexcitability of PrL PN on a shorter time-scale. 33
To identify the temporal and sex-specific nature of opioid-induced mPFC dysfunction, male and 34 female mice underwent 10-16 (short-term) or 25-30 days (long-term) of remifentanil (Ultiva®) self-35 administration followed by 14-21 or 40-45 days of forced abstinence (Fig. 1a ). Remifentanil males 36 and females had similar active and inactive lever pressing across the first 10 and 25 days in short-37 and long-term self-administration, respectively ( Fig. 1b, 1e ). Cumulative earned infusions was 38 greater in long-term remifentanil mice compared to short-term, with females showing greater 39 cumulative intake versus males with more prolonged self-administration ( Fig. 1c, 1f) . 40 
41

Remifentanil Effects on mPFC Layer 5/6 Pyramidal Neuron Intrinsic Excitability 42
Functional integrity of mPFC information processing and PN output is dependent on 43 extrasynaptic factors that dictate neuronal firing threshold and how cells respond to synaptic 44 input [12] [13] [14] [15] . Thus, we used ex vivo electrophysiology to examine these properties in PrL PN 45 following remifentanil self-administration. Intrinsic excitability of deep-layer (L5/6) PrL PN was 46 assessed by measuring current required to evoke an initial action potential (rheobase) in 47 response to depolarizing current steps (1 s, -80-380 pA, 20 pA steps). Following 14-21 days 48 abstinence, PN in short-term remifentanil males showed a reduction in threshold to fire an 49 action potential (hyperexcitability), whereas short-term females exhibited an increased threshold 50 to fire (hypoexcitability; Fig. 1d ). Following prolonged abstinence (45 days), hypoexcitability in 51 females but not hyperexcitability in males was still present (Supplemental 1). Following 14- 21 52 days abstinence from long-term self-administration, PrL PN in female and males exhibited an 53 equivalent hypoexcitability compared to controls (Fig. 1g) . These data indicate that long-term 54 opioid self-administration produces a hypoactive state in PrL PN that emerges more rapidly in 55 females that is independent of drug intake and more enduring than hyperexcitability in males. 56
Further, as PN in females show increased excitability under basal conditions akin to short-term 57 remifentanil males, hyperexcitability in males may reflect permissive plasticity in the transition to 58 hypoactive states and heightened susceptibility in females. 59
Clinical studies in opiate-dependent individuals indicates that the human equivalent of 60 the mPFC exhibits a dichotomous reduction in basal metabolic activity but heightened activity 61 during cue-induced craving 6, 8, 9, 16 . Further, PFC dysfunction and impaired cognition in numerous 62 pathological states has been linked to reduced or increased/irregular spike firing activity 17-20 --63 highlighting the importance of spike firing in cortical processing and opiate addiction pathology. 64
Following short-term remifentanil self-administration, PN in males exhibited a leftward shift 65 (increase) in firing frequency in response to depolarizing current steps ( Fig. 1h ) that was no 66 longer present at 45 days (Supplemental 1), whereas PN in females exhibited increased firing 67 capacity at depolarized currents ( Fig. 1i ) that persisted up to 45 days (Supplemental 1). Following 68 more prolonged self-administration, PN in both male and female remifentanil mice exhibited 69 divergent shifts in firing capacity at low versus high currents ( Fig. 1j, 1k ). These data indicate that 70
PrL PN are less likely to fire but exhibit increased firing capacity once activatedpotentially 71 explaining the dichotomy in PFC activation observed in humans in basal versus craving states. 72
Notably, no significant effects on excitability were observed in infralimbic cortex PN following 73 short-or long-term self-administration (Supplemental 2) suggesting adaptations may be time-, 74 cell-, or pathway-specific [21] [22] [23] . 75
76
Remifentanil Effects on PrL Pyramidal Neuron Inhibitory and Excitatory Signaling 77
Activation and firing patterns of PN are heavily influenced by synaptic and perisynaptic 78 excitatory and inhibitory signaling at the soma and dendrites 13, 14 . Cocaine-induced 79 hyperexcitablity of PrL PN and their increased responsivity to cocaine and related stimuli 24 has 80 been linked to adaptations in multiple ion conductances in PN [25] [26] [27] [28] , including weakening of 81 GABABR-dependent activation of G protein inwardly-rectifying K+ channels (GABABR-GIRK) 29 . 82
Following short-term self-administration, hyperexcitability in males but not hypoexcitablity in 83 females, aligned with reduced somatodendritic currents evoked by the GABABR agonist, baclofen 84 (IBaclofen; 200 µM; Fig. 2a, 2b) , which similar to rheobase and spike firing, was not present at 45 85 days abstinence (Supplemental 1). 86
Previous studies have implicated mPFC excitatory:inhibitory synaptic and structural 87 modifications in opioid sensitivity and reinstatement [30] [31] [32] [33] , no known studies have directly measured 88 synaptic adaptations following abstinence from opioid self-administration selectively in PrL PN. 89
Given the lack of change in IBaclofen in females, we next examined modifications in excitatory and 90 inhibitory synaptic transmission by measuring AMPA receptor (AMPAR)-specific miniature 91 excitatory postsynaptic currents (mEPSCs) and GABAAR-specific inhibitory postsynaptic currents 92 (mIPSCs). PN from short-term remifentanil females showed reductions in mEPSC frequency ( Fig.  93 2d-e) and increased frequency of mIPSCs compared to controls ( Fig. 2f -g), with no effects on 94 mEPSC or IPSC amplitude. Saline males exhibited a lower baseline of mEPSC frequency versus 95 females; with only a trend towards reduced mIPSC frequency in remifentanil versus saline males 96 ( Fig. 2f-g) . These data indicate that mechanisms underlying hyperexcitabilty and hypoexcitability 97 vary, with hypoexcitability aligning with a shift towards synaptic inhibition, and that sex differences 98 in basal excitatory transmission may also confer abuse susceptibility. 99
PrL dysfunction has been linked to impairments in flexible behavior, affect dysregulation, 100 and increased risk for developing compulsive/impulsive behavior -all of which are observed in 101 opioid dependent subjects and aligns with poor (relapse) treatment outcome in cocaine 102 addicts 8, 9, 30, [34] [35] [36] , however little is known regarding the influence of biological sex on these risk 103 factors or mechanisms underlying this dysfunction. We first examined whether hypo-(or hyper-) 104 active PN states equate to changes in anxiety-and depressive-like behaviors. Short-term self-105 administration, a time point in which we see differences in male and female plasticity, did not 106 alter anxiety-or depressive-like coping behaviors as measured in the elevated plus maze or 107 forced swim test (Supplemental 3). As the PrL is critical for cognitive flexibility 10,37 , we next 108 used an attentional set-shifting model to measure deficits in cognitive flexibility --a task that 109 resembles the Wisconsin Card Sorting Task in the sense that the stimuli are easy to detect, but 110 rules are implicit and learned while the task is performed ( Fig. 3a ). Similar to previous lesion 111 studies of the PrL 38 , learning of the visual cue discrimination task was unaltered by short-term 112 remifentanil in males or females ( Fig. 3b ). Alternatively, remifentanil in females increased the 113 number of trials and errors to reach criteria during an extradimensional (cue-to-response) set-114
shift test compared to saline females and remifentanil males ( Fig. 3c ). Deficits cannot be 115 attributed to differences in acquisition of lever training or omission of response as no 116 differences in these measures was observed (Supplemental 4). Further, performance in 117 reversal learninga task more reliant on the orbitofrontal region 39 --was unaffected by 118 remifentanil in males and females (Supplemental 5). A critical step in future studies will be 119 determining what role, if any, gonadal hormones have on these remifentanil-induced deficits, 120
as recent work has demonstrated a role of estrous stage on cue/drug associations 40 , heroin 121 self-administration 41 , and unconstrained remifentanil demand 42 . 122 123
Impact of Remifentanil on Affective Behavior and Cognitive Flexibility 124
We propose that if PrL PN hypoexcitability underlies reductions in cognitive flexibility 125 following repeated drug use, compensating this should restore flexibility. We used an in vivo 126 chemogenetic approach to express the excitatory AAV8-hm3d-Gq designer receptor 127 exclusively activated by designer drugs (DREADD) in CaMKII-expressing cells (i.e., PN) in 128 female mice undergoing remifentanil self-administration ( Fig. 3d ). Ex vivo analysis of CNO 129 effects on PN rheobase showed that CNO bath application (5µM) lead to spontaneous firing in 130 4 out of 5 cells. Interestingly, CNO treatment also significantly reduced rheobase in non-virus 131 expressing and GFP-control expressing PN, albeit to a lesser extent ( Fig. 3e ). No differences 132 across treatment groups was observed in lever training or trials to criteria during the visual cue 133 test (Supplemental 6). Injection of the DREADD agonist, clozapine-N-oxide (CNO; 5 mg/kg), 134 into mice 30 minutes prior to extradimensional set-shift testing significantly reduced trials and 135 errors to reach criteria compared to remifentanil exposed females and akin to performance in 136 saline controls ( Fig. 3f -g). Although not significant, CNO administration in remifentanil females 137 expressing a GFP-control virus produced a trend towards better performance. These data, 138
along with the effect of CNO on GFP-control neurons, suggests that partial recovery of set-139 shifting may reflect back metabolism of CNO to clozapine 43 which improves set-shifting 140 performance in rats 44 . Regardless, this is the first evidence that opioid-induced hypofrontality 141 underlies cognitive inflexibility and a potential means by which women transition to uncontrolled 142 drug-seeking on a more rapid time scale, highlighting this as a critical preventative therapeutic 143 target. 144
145
DISCUSSION/CONCLUSION 146
The current results demonstrate that low dose self-administration of a clinically used short-147 acting opioid (i.e. remifentanil) is sufficient to promote an enduring hypoexcitable state akin to that 148 in cocaine and heroin addicted individuals 8, 9 which emerges on a shorter time-scale in females 149 and directly contributes to deficits in flexible decision-making 8, 11, 45 . A similar hypoexcitable state 150 was observed following eight weeks of cocaine self-administration in males that underlies 151 compulsive drug-seeking 11 , thus opioids may promote a faster transition towards reduced 152 cognitive control. Our data highlight important considerations for clinical use and highlight a sex 153 difference in risk for developing early deficits in cognitive control that likely increases risk of opioid 154 misuse and addiction on a shorter timescale than previously thought. Although the mechanisms 155 responsible for this more rapid shift require further exploration, we find that PN in females are 156 intrinsically more excitable compared to males. As a similar hyperexcitable state was observed 157 following short-term opioid exposure in males, it is possible that this adaptation represents a 158 permissive functional plasticity that serves to lower the rheobase in females under naïve 159 conditions 46 . Together, the current results fill critical gaps in understanding the influence of self -160 administered opioid use on mPFC states and how these contribute to cognitive flexibility in 161 both males and females, which has implications for sex-specific targets to mitigate opioid Sodium (5mg/mL). 180
Opioid self-administration. To facilitate acquisition of opioid self-administration, mice were 181 initially food-restricted to maintain a weight of 85-90% their original body weight and were 182 habituated overnight to 50% liquid Ensure (diluted with water). The current study utilizes the 183 highly μOR-specific and potent synthetic opioid, remifentanil HCl (Ultiva®; Mylan Institutional, 184 LLC; purchased from Froedtert Hospital Pharmacy, Milwaukee, WI), whereby pressing the left 185 lever resulted in delivery of both liquid Ensure (50%; Abbott Laboratories) and intravenous 186 infusion of either saline or 5µg/kg/infusion based on previous dosing in mice and rats [47] [48] [49] . 187
Conversely, pressing the right lever resulted in no consequence. 188
In most instances, mice were trained to press a lever on an increasing fixed ratio 189 schedule using a liquid dipper system (Med Associates, Inc.). Training involved reaching a 190 criterion of 25 (fixed ratio 1), 50 (fixed ratio 2), and 100 (fixed ratio 3) dipper/infusions on a 191
given day and an increasing fixed ratio schedule was enforced, with reaching criteria necessary 192 before progressing (i.e. Paired). Following completion of FR3 paired with 100 dipper/infusions, 193 mice were given 1-3 days of abstinence followed by one self-administration session for the 194 remifentanil or saline alone and then food was returned ad libitum. In a subset of mice, 195 acquisition involved responding on a fixed ratio 1 schedule for ensure alone for one day, then 196 responding on a fixed ratio 1 schedule for remifentanil or saline alone for the remainder of self-197 administration (i.e. Unpaired). Importantly, there were no differences in PrL rheobase of 14 day 198 saline male mice that received Mice were allowed to recover for five days then were food deprived to 85-90% of their free 210 feeding weight to be ran in the attention set-shifting task, as described below. Mice with viral 211 infusions were given a saline intraperitoneal injection 30 minutes prior to testing in t he visual 212 cue test. On the day of the extradimensional shift, mice were given 5mg/kg clozapine -n-oxide 213 (CNO; Tocris Biosciences, Cat. No: 4936). 214
Elevated plus maze. The morning following the last self-administration sessions, a subset of 215 mice were tested for anxiety-like behaviors using the elevated plus maze as previously 216 
Forced swim test.
A subset of mice were tested for immobility in a forced swim test 220 approximately 16 days following the last day of self-administration, as previously described 50 . 221
Briefly, mice were placed in an inescapable 800mL glass jar that was filled with 25°C water 222 and were habituated for two minutes. The test consisted of four minutes during which the time 223 immobile was measured using AnyMaze tracking software (Stoelting Co.). This test was 224 performed following testing with the set-shifting task to avoid confounds of acute stress on 225 subsequent behavior. 226 Attention set-shifting task. Cognitive flexibility was measured using an operant based 227 attentional set-shifting task that was modified based off of methods previously described 51 . 228
Three to seven days following the last self-administration session, mice were food-deprived 229 85-90% of their free feeding weight. Training and testing was done in the operant chamber that 230 was used for self-administration (Med Associates, Inc). During food training, a fixed ratio 1 231 schedule was used, whereby a right lever response (opposite lever to the reinforced lever 232 during self-administration) resulted in delivery of a 50% liquid Ensure reward. Food training 233 sessions were 30 minutes in length and required mice to earn 50 rewards to progress to lever 234 training. During lever training, levers were extended pseudorandomly with no more than two 235 consecutive extensions of each lever. Mice were required to press the lever within 10 seconds 236 of extension to receive a 50% liquid Ensure reward, absence of which was deemed as an 237 omission but was not counted as a trial. Lever training consisted of a total of 90 trials (45 of 238 each the left and right lever), with each followed by a 20 second time out. Mice had to reach 239 criteria of five or fewer omissions on two consecutive days. Once lever training criteria was 240 reached, lever bias was assessed through 7 trials, during which both the left and the right lever 241 were reinforced. 242
The following day, visual cue testing was conducted until 150 trials or a streak of 10 243 consecutive correct responses, whichever occurred first. The correct response was the lever 244 below the illuminated cue light and resulted in delivery of the ensure reward and a time out. 245
Omissions were counted as stated above. If this criterion was not reached on the first day of 246 testing, a second or third day of testing was conducted. The day following visual cue testing, 247 extradimensional shift testing was conducted and the reinforced lever was always the lever 248 opposite of the bias, however during this test the cue light was presented in a manner/order 249 similar to that during the visual cue test. Following criteria of the extradimensional shift, 250 reversal testing was conducted during which the reinforced lever was always that of the bias, 251 however the cue light was presented as above. The criterion for both the extradimensional shift 252 and reversal test was the same as the visual cue test. Once all attentional set -shifting tests 253 were complete, food was provided ad libitum for the remainder of the experiments. 254 Slice electrophysiology. Acute slice electrophysiology was performed either 14-21 or 40-45 255 days following the self-administration session. Mice were mildly anesthetized with isoflurane 256 (Henry Schein), decapitated, and the brain removed and put in ice-cold sucrose solution 257 oxygenated using 95% O2 5% CO2. A vibratome (Leica VT1000S) was used to obtain coronal 258 slices (300µm) containing the mPFC. Slices were immediately incubated at 31°C for 10 minutes 259 in a solution 119mM NaCl, 2.5mM KCl, 1mM NaH2PO4, 26.2mM NaHCO3, 11mM glucose, 0.4mM 260 ascorbic acid, 4mM MgCl2, and 1mM CaCl2. Slices were then removed, allowed to cool to room 261 temperature and incubated further for a minimum of 35 min. 262
Whole-cell recordings were performed as previously described 29, 50 . Briefly, slices were 263 gravity perfused with oxygenated ACSF at a temperature of 29°C-33°C using at a flow rate of 264 ~2-2.5 ml/min. Sutter Integrated Patch Amplifier (IPA) with Igor Pro (Wave Metrics, Inc.) was used 265 for the data acquisition software. Recordings were filtered at 2kHz and sampled at 5kHz for 266 current-clamp recordings and voltage-clamp recordings assessing baclofen-evoked currents. 267
Miniature postsynaptic current recordings were filtered at 2kHz and sampled at 20kHz. rheobase, mEPSC/mIPSC frequency/amplitude, Ibaclofen) as well as behavior tests involving 293 EPM, FST, and ASST were determined using 2 (male, female) x 2 (saline, remifentanil) 294 analysis of variance. For current-spike analysis (Fig. 1, Supplemental 1-2) , two-way 295
(frequency x current) repeated measure ANOVA was used. For subsequent analysis of 296 DREADD rescue, a one-way ANOVA RM for within-cell analysis was used. Here, data from 297 saline and remifentanil mice were combined with additional animals and groups (GFP control, 298 GqDREADD). When interactions were found, main effects were not reported. Student-299
Newman-Keuls post-hoc comparisons were conducted when necessary. mIPSCs/mEPSCs 300 were analyzed using MiniAnalysis software using a 5pA detection threshold (Synaptosoft). 301
Data was analyzed using Sigma Plot (Systat Software, Inc) and graphed using Prism 7.0 302 (GraphPad). The threshold for statistical significance was p<0.05. Statistical outliers were 303 defined as being at least 2 standard deviations away from the mean and were removed from 304 analyses. A total of 6 cells were deemed as outliers for electrophysiology recordings (n=3 for 305 mPSCs; n=3 for rheobase), with no more than one per experimental group removed. For 306 behavior studies, no statistical outliers were removed. For electrophysiology studies, in most 307 instances, no more than 3 recordings were used for a given metric (e.g., mEPSCs) from the 308 same animal to reduce data bias. Exceptions were made when multiple recordings were 309 acquired by different electrophysiologists on a given day for a total of n=4/animal. . j, Current-spike analysis showed firing frequency was reduced at lower currents but increased at more depolarized potentials in remifentanil (N/n=6/12) versus saline (N/n=8/16) males (interaction: F(19,551)=4.74,*p<0.05, ***p<0.001). k, Remifentanil females (N/n=4/9) had reduced firing frequency at lower currents but similar firing frequency at more depolarized potentials versus saline females (N/n=5/9) (Two-way RM: F(19,304)= 2.95, p<0.001). All data are presented as the mean ± SEM. Figure 2 . Remifentanil effects on PrL L5/6 PN excitatory and inhibitory plasticity in males and females. a, Self-administration and abstinence timepoints. b, Mean baclofen-evoked currents (IBaclofen) from male (unfilled) and female (filled) PrL L5/6 PN 14-21 days after 10-14 day remifentanil (blue) or saline (gray). A significant sex by treatment interaction was observed following short-term abstinence (F (1, 28) =9.63, p<0.01). Currents were reduced in remifentanil males (N/n=6/8) versus saline (N/n=11/13, ***p<0.001). Saline females (N/n=5/5) showed similar IBaclofen compared to remifentanil (N/n=3/6, p=0.35). c, Representative IBaclofen traces following 14-21 d abstinence. d, Mean frequency (left) and amplitude (right) of miniature excitatory postsynaptic currents (mEPSCs) following short-term abstinence. An interaction was observed for mEPSC frequency (F (1, 53) =5.06, p=0.03). Saline females (N/n=6/8) exhibited elevated frequency compared to saline males (N/n=8/16; #p=0.016) and remifentanil females (N/n=8/15, *p=0.023), with no change in remifentanil versus saline males (N/n=8/15, p=0.45).
No main effects or interaction was observed for mEPSC amplitude (sex: F (1, 53) =1.48, p=0.23; treatment: F=0.79, p=0.38; interaction: F= 0.01, p=0.94). e, Representative mEPSCs (recorded at -72 mV) from PrL L5/6 PN. f, Mean frequency and amplitude of miniature inhibitory PSCs (mIPSCs) following shortterm abstinence. A significant interaction was observed for mIPSC frequency (F (1, 45) =17.85, p<0.001). Frequency was increased in remifentanil (N/n=10/13) versus saline (N/n=6/11) females (***p<0.001), with no differences in remifentanil (N/n=5/8) versus saline (N=8/17, p=0.13) males. A significant effect of sex, but not treatment or interaction was observed for mIPSC amplitude (sex: F (1, 45) =10.19, **p=0.003; treatment: F=2.18, p=0.15; interaction: F=0.11, p=0.74). g, Representative mIPSCs (recorded at 0 mV) from PrL L5/6 PN. Figure 3 . Opioid-induced PrL L5/6 PN hypoactivity produces deficits in cognitive flexibility but not affect. a, Timeline of behavioral assessments following self-administration and schematic of operant setshifting paradigm depicting levers (gray), dipper (white), cue location (yellow) and correct response (star). b, Mean trials (left) and errors (right) to criteria for visual cue test. No significant main effect of sex or treatment, or interaction was observed for trials or errors to criteria (sex: trials (F (1, 25) =0.02, p=0.89), errors (F (1, 25) =0.00, p=0.99); treatment: trials (F (1, 25) =0.06, p=0.81), errors (F (1, 25) =0.01, p=0.94); interaction: trials (F (1, 25) =0.09, p=0.76), errors (F (1, 25) =0.10, p=0.76). c, Mean trials and errors to criteria for extradimensional (ED) cue-to-response shift. A significant interaction was observed for trials (F (1, 28) =10.19, p=0.004) and errors (F (1, 28) =10.48, p=0.003). Remifentanil females (N=7) required significantly more trials and exhibited more errors compared to saline females (N=6, trials: **p=0.003, errors: **p=0.002) and remifentanil males (N=9; trials: ##p=0.002, errors: ##p=0.004), whereas performance in remifentanil males did not differ compared to saline males (N=7). Figure 1 . Increased rheobase in females following remifentanil self-administration is enduring. a, Self-administration and abstinence timeline. b, Following 45 day abstinence, no significant difference in rheobase was observed in remifentanil males (Sal: N/n=7/12, Rem: N/n=10/18, p=0.50) while rheobase remained increased in remifentanil females (N/n=5/9) versus saline (N/n=7/14, **p=0.009; interaction: F (1, 48) =6.37, p=0.02). c, Current-spike analysis showed no difference in firing frequency across current in remifentanil males (N/n=7/12) compared to saline (left; N/n=9/16; treatment: F (19, 494) = 0.69, p=0.83), and a significant treatment by current interaction in females (F (19, 361) = 2.46, p<0.001), with a trend towards increased firing at higher currents in remifentanil mice (N/n=4/8) compared to saline (N/n=6/13; +p<0.10). d, No significant effect of sex, treatment, or interaction on IBaclofen was observed following 40-45 days of abstinence (right; sex: F (1, 24) =1.88, p=0.18; treatment: F=0.24, p=0.63; interaction: F=0.04, p=0.85). Figure 4 . Differences in ASST performance were not influenced by differences in acquisition of lever training or omissions. a, All groups took similar amount of time to acquire lever training (sex: F (1, 25) =0.43, p=0.52; treatment: F (1, 25) =2.50, p=0.13; sex by treatment: F (1, 25) =0.39, p=0.44). b, There were no differences in omissions during the visual cue test (sex: F (1, 25) =1.06, p=0.31; treatment: F (1, 25) =0.19, p=0.67; sex by treatment: F (1, 25) =1.62, p=0.22). c, There was not a significant difference in omissions during extradimensional set shift testing between sex (F (1, 25) =1.06, p=0.31) or a sex by treatment interaction (F (1, 25) =1.24, p=0.28) however there was a main effect of treatment (F (1, 25) =4.41, p=0.05) but both saline and remi mice had overall low omissions (saline: 0.38 ± 0.18 omissions; remi: 4.08 ± 2.63 omissions). Figure 5 . Remifentanil self-administration does not alter performance in the reversal test. a, No significant effects of sex, treatment, or interaction of sex by treatment were observed for trials to criteria during the reversal test (sex: F (1, 24) =0.06, p=0.81; treatment: F=0.09, p=0.77; interaction: F=0.82, p=0.38. b, No significant effects of sex, treatment, or interaction of sex by treatment were observed for errors to criteria during the reversal test (sex: F (1, 24) =0.09, p=0.77; treatment: F=0.03, p=0.87; interaction: F=1.23, p=0.28). c, There was a significant sex by treatment interaction in omissions during the reversal test (F (1, 24) =4.89, p=0.04, however no post-hoc analyses were significant. a, There were no differences in days to reach lever training criterion between salineexposed, remi-exposed, remi-exposed with Gq-DREADD, and remi-exposed with GFP-control virus (F (3, 23) = 0.47, p=0.71). b, An injection of saline prior to the visual cue test did not influence trials to reach criteria (F (3, 23) =0.17, p=0.92), errors to criteria (F (3, 23) =0.23, p=0.87; not shown), or the number of omissions during testing (F (3,23) = 1.50, p=0.24; not shown). c, Exposure to CNO the day prior did not significantly influence trials to criteria during the reversal test (F (3, 22) =0.76, p=0.53), errors (F (3, 22) =0.49, p=0.69; not shown), or omissions (F (3, 22) =1.71, p=0.20). Supplementary Figure 7 . Paired Ensure-Infusion training increases active lever pressing in saline, but not remifentanil, male mice. A portion of mice were trained using Ensure paired with remifentanil or saline for three days on an increasing fixed ratio schedule (Paired) whereas others received a single day of Ensure that was not paired with an infusion (Unpaired). a, Paired male mice receiving saline infusions prior to saline self-administration had significantly more active lever presses (gray filled, square) than saline Unpaired males (interaction: F (9, 261) = 7.44, p<0.001, training type: F (1, 29) = 4.83, p=0.04; ***p<0.001) but no differences were observed with inactive lever pressing (circles) (interaction: F (9,261) = 0.95, p=0.48, training type: F (1, 29) = 0.52, p=0.48). b, There was no main effect of training type on active lever pressing in males self-administering remifentanil (F (1, 17) = 0.58, p=0.46), however there was a day by training interaction (F (9, 153) =5.41, p<0.001). Higher active lever responding was observed in Paired versus Unpaired remifentanil mice only on the first day following ensure training (***p<0.001). Paired mice also had greater inactive lever pressing on the two days following ensure training (interaction: F (9, 153) = 2.95, p<0.01, training type: F (1, 17) = 1.42, p=0.25; +p<0.05). c, Total remifentanil intake (infusions) did not differ in Paired versus Unpaired mice (t (17) =-1.58, p=0.13), and did not correlate to average PrL rheobase for Unpaired (p=0.88) or Paired (p=0.73) mice.
